Cas:100587-90-4 Lanthanum acetate hydrate (1:3:1) manufacturer & supplier

We serve Chemical Name:Lanthanum acetate hydrate (1:3:1) CAS:100587-90-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Lanthanum acetate hydrate (1:3:1)

Chemical Name:Lanthanum acetate hydrate (1:3:1)
CAS.NO:100587-90-4
Synonyms:LANTHANUM ACETATE HYDRATE;Lanthanum(Iii) Acetate Hydrate;MFCD00150118;EINECS 213-034-8;Acetic acid, lanthanum salt, hydrate (3:1:1);Lanthanum acetate hydrate (1:3:1)
Molecular Formula:C6H11LaO7
Molecular Weight:334.053
HS Code:

Physical and Chemical Properties:
Melting point:110°C
Boiling point:N/A
Density:1.640
Index of Refraction:
PSA:88.13000
Exact Mass:333.956818
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like LANTHANUM ACETATE HYDRATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Lanthanum acetate hydrate (1:3:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetic acid, lanthanum salt, hydrate (3:1:1) Use and application,EINECS 213-034-8 technical grade,usp/ep/jp grade.


Related News: It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. Lanthanum acetate hydrate (1:3:1) manufacturer Both were in Siberia, and both are Chinese nationals who had recently traveled to China. Lanthanum acetate hydrate (1:3:1) supplier Both were in Siberia, and both are Chinese nationals who had recently traveled to China. Lanthanum acetate hydrate (1:3:1) vendor In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC. Lanthanum acetate hydrate (1:3:1) factory In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.